Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2025Regulâtornye issledovaniâ i èkspertiza lekarstvennyh sredstv.Open Access

EAEU Development and Production of Radiopharmaceuticals: Major Achievements, Growth Vectors, and Prospects

View Full Paper
Ask AI
Bookmark
Share

Authors

DRD. A. Rozhdestvensky

Discussion

Loading...

Member takes

Overview

The plan aims for technological self-sufficiency in the pharmaceutical industry, focusing on radiopharmaceuticals and radionuclide therapy.

Key Points

  • Major progress in the Russian pharmaceutical industry enhances production of radiopharmaceuticals.
  • The development plan outlines steps to achieve self-sufficiency by 2030, emphasizing research and production.
  • Insights from industry experts highlight the importance of authorized application of radionuclide therapy in EAEU states.
  • Strengthening the pharmaceutical sector supports overall health initiative across Eurasian Economic Union member states.

Cite This Study

D. A. Rozhdestvensky (2025) studied this question.

synapsesocial.com/papers/68c23922b210217d6477b11fhttps://doi.org/10.30895/1991-2919-2025-15-4-372-376
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Developing Marketing Authorisation Dossier of a Radiopharmaceutical: The EAEU Procedure2025 · 1 citations
  2. 2Regulatory Requirements for Small-Scale Preparation of Radiopharmaceuticals2025 · 2 citations
  3. 3STATE SUPPORT FOR THE INDUSTRIAL PRODUCTION OF ACTIVE PHARMACEUTICAL SUBSTANCES IN THE RUSSIAN FEDERATION2025
  4. 4Analysis of Global Patenting Trends in Radiopharmaceutical Industry: Diagnostics, Therapy, and Theranostics2025
  5. 5Economic security aspects of pharmacology and pharmaceutics in the Russian Federation: navigating emerging challenges2025